These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 16519795
1. Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. Montesinos MC, Desai A, Cronstein BN. Arthritis Res Ther; 2006; 8(2):R53. PubMed ID: 16519795 [Abstract] [Full Text] [Related]
3. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. Kreckler LM, Wan TC, Ge ZD, Auchampach JA. J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914 [Abstract] [Full Text] [Related]
4. Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation. Delano DL, Montesinos MC, Desai A, Wilder T, Fernandez P, D'Eustachio P, Wiltshire T, Cronstein BN. Arthritis Rheum; 2005 Aug; 52(8):2567-75. PubMed ID: 16059892 [Abstract] [Full Text] [Related]
6. Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation. Rogachev B, Ziv NY, Mazar J, Nakav S, Chaimovitz C, Zlotnik M, Douvdevani A. Kidney Int; 2006 Aug; 70(4):675-81. PubMed ID: 16788688 [Abstract] [Full Text] [Related]
15. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes. Sun WC, Moore JN, Hurley DJ, Vandenplas ML, Linden J, Cao Z, Murray TF. Vet Immunol Immunopathol; 2008 Jan 15; 121(1-2):91-100. PubMed ID: 17913243 [Abstract] [Full Text] [Related]
16. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Gomez G, Sitkovsky MV. Blood; 2003 Dec 15; 102(13):4472-8. PubMed ID: 12947007 [Abstract] [Full Text] [Related]